Phibro Animal Health buys Argentine company

By Lynda Cohen
Teaneck | Sep 13, 2017 at 9:45 am

Teaneck-based Phibro Animal Health Corp. is expanding its business with the purchase of an Argentine developer, manufacturer and marketer of animal health and nutritional products.

The purchase of Biotay S.A. also will give Phibro new opportunities in a growing segment of the animal health industry in South America, the company announced.

“This transaction strengthens our focus and capabilities in the animal health market in Argentina,” Phibro Chief Operating Officer Larry Miller said. “Biotay’s field sales and technical service organization and local manufacturing will help Phibro reach new customers, particularly in the cattle segment. Adding our products to Biotay’s in-depth local knowledge will allow us to better meet our customers’ needs in this key geography.”

Biotay CEO Juan Carlos Repetto said the company is “delighted to become part of such a world-class organization as Phibro.

“We are excited and looking forward to leveraging the strengths of both organizations and resources to better serve our customers. Phibro’s proven expertise and innovative platforms will provide strategic resources to maximize Biotay’s customer service capabilities, providing our customers with increased animal health, productivity and nutrition quality while improving animal welfare.”

Argentina’s animal health industry is key in leveraging growth in South America, Miller said.

“Phibro and Biotay share core values, including a proactive vision for working collaboratively with customers to provide customized animal health solutions,” he said. “We welcome Biotay’s dedicated team of employees to Phibro; I am particularly enthused about the high level of talent, experience and key customer relationships our new colleagues from Biotay bring. Our combined organization represents a platform for growth and value creation, building on the history and strong reputation of both companies.”

Repetto will lead the combined Argentina organization.

The deal’s financial terms were not released.